What to prioritize next
Preview text: Sourcing from years of material, we've curated a path through the science on topics that…

Using this email in an article? Credit: Peter Attia, M.D. email via They Sent It, with a link to this page. Full-size image
- Subject
- What to prioritize next
- Preview text
- Sourcing from years of material, we've curated a path through the science on topics that…
- From
- peter@
peterattiamd.com - Brand
- Peter Attia, M.D.
- ESP
- Klaviyo
- Sent
- Thu Sep 17, 2026, 7:52 AM ET
- Sent to
- peterattiamd.com
- Size
- 45 KB
- Images
- 9
- Links
- 10, 5 of them buttons
- Subject length
- 23 characters
Against Peter Attia, M.D.'s usual
Sent in its busiest hour, 7 AM, which holds 100% of its emails. The subject is 23 characters; its average is 66.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Peter Attia, M.D. <[email protected]>
- Subject
- What to prioritize next
- Date
- Thu, 17 Sep 2026 11:52:42 +0000
- Message-ID domain
- klaviyomail.com
- Return-Path domain
- k3.send.peterattiamd.com
- DKIM signature
- d=shared.klaviyomail.com s=def1; d=send.peterattiamd.com s=mtd1
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from (unnamed) by kmta-mta-blue-….servers.clovesoftware.com with SMTP
Other sending headers (names only): X-Mailer-Info-Extra2, X-Mailer-Info, X-Mailer-Info-Extra, X-Kmail-Account, X-Kmail-Flow, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse
Sent just before and after
| Sep 27, 2026 7:02 AM | Prioritizing health interventions | |
| Sep 21, 2026 7:01 AM | Thyroid health: interpreting symptoms, diagnosing and treating dysfunction, and navigating the gray zone | |
| Sep 20, 2026 7:02 AM | Can semaglutide slow aging? | |
| Sep 17, 2026 7:52 AM | What to prioritize next (this email) | |
| Sep 14, 2026 7:01 AM | Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and promising new therapies | |
| Sep 13, 2026 7:51 AM | Limited Time Offer to Go Deeper with Premium | |
| Sep 13, 2026 7:00 AM | Nearsightedness is rising. Are screens to blame? |
More from Peter Attia, M.D.
All Peter Attia, M.D. emailsNov 2, 2026 7:02 AM
Who is actually at risk for CTE?
Nov 1, 2026 7:00 AM
A longevity playbook for building strength and muscle mass
Oct 29, 2026 7:00 AM
Oct 26, 2026 7:01 AM
Personalized medicine comes to cancer immunotherapy
Oct 25, 2026 7:03 AM
Oct 19, 2026 7:01 AM
The [almost] unbelievable relationship between “big pharma” and gray-market peptides
Oct 18, 2026 7:00 AM
Oct 12, 2026 7:02 AM
Sent the same day by similar brands
Same ESP and the closest weekly volume, sent on Sep 17, 2026.






![The [almost] unbelievable relationship between “big pharma” and gray-market peptides - email from Peter Attia, M.D.](https://img.theysentit.com/peter-attia-md/5204895.t.jpg)

